Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 251–263 of 263 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02474641	Hypofractionation With Simultaneous Integrated Boost vs. Standard Fractionation in Early Breast Cancer(HYPOSIB)	active not recruiting	N/A	2,324	University Hospital Schleswig-HolsteinOTHER	1	Mar 21, 2024	clinicaltrials
NCT06271044	a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS	active not recruiting	N/A	61	Helsinki University Central HospitalOTHER	0	Feb 21, 2024